New diabetes clinical trial: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
Published on: 2026-04-09T04:00:00Z Conditions : Diabetic Retinopathy (DR); Diabetic Macular Edema (DME) Interventions : Drug: Faricimab; Drug: Biosimilar ranibizumab Sponsors : Osijek University Hospital Recruiting https://ift.tt/OqfY0kC